[Bloodless treatment of coxarthropathy].
COSTE F.
Reumatismo. 1957 Nov-Dec;9(6):313-7.
[Expression of matrix metalloproteinases (MMPs) and tissue inhibitor of metalloproteinases (TIMPs) in joint tissues of rapidly destructive coxarthropathy (RDC), analyzed by immunohistochemical study].
Matsumoto F, Uzuki M, Kaneko C, Rikimaru A, Kokubun S, Sawai T.
Ryumachi. 1997 Oct;37(5):688-95.
Rapidly destructive coxarthropathy with osteonecrosis and osteoporosis caused by Cushing's syndrome.
Takada J, Nagoya S, Kuwabara H, Kaya M, Yamashita T.
Orthopedics. 2004 Oct;27(10):1111-3. doi: 10.3928/0147-7447-20041001-25.
[Surgical indications in coxarthropathy].
DEBEYRE J, DOLIVEUX P.
Rev Rhum Mal Osteoartic. 1954 Jan;21(1):76-9.
Massive accumulation of osteoclastic giant cells in rapid destructive hip disease.
Seitz S, Zustin J, Amling M, Rüther W, Niemeier A.
J Orthop Res. 2014 May;32(5):702-8. doi: 10.1002/jor.22573. Epub 2014 Jan 31.
Clinical and radiographic outcomes of primary total hip arthroplasty with the revelation hip system using density mapping.
Sakai H, Watanabe N, Kuroyanagi G, Fukuoka M, Usami T, Ueki Y, Murakami H.
Eur J Orthop Surg Traumatol. 2023 Feb;33(2):435-440. doi: 10.1007/s00590-022-03210-5. Epub 2022 Jan 29.
[Relation between coxarthropathy and spondylosis lumbalis].
THULCKE E.
Dtsch Gesundheitsw. 1953 May 21;8(21):616-8.
[Expression of urokinase-type plasminogen activator (uPA) and uPA receptor (uPAR) plays a role in destruction of joint tissue in rapidly destructive coxarthropathy (RDC)].
Tamura N, Uzuki M, Matsumoto F, Rikimaru A, Kokubun S, Sawai T.
Ryumachi. 2001 Oct;41(5):851-7.
[Coxarthroses due to ischemia. Ischemic coxarthropathy].
Arlet J, Ficat P, Mazières B.
Rev Rhum Mal Osteoartic. 1978 Oct;45(10):549-60.
[Indications and results from surgical treatment of coxarthropathy].
PAJAULT A.
Concours Med. 1956 Sep 1;78(35):3723-9.
